Central Sleep Apnea in Children-10 Years Experience at a Tertiary Sleep Laboratory

Cansu Yılmaz Yeğit,Mine Kalyoncu,Mürüvvet Yanaz,Aynur Guliyeva,Merve Selçuk,Şeyda Karabulut,Meltem Sabancı,Pınar Ergenekon,Yasemin Gökdemir,Fazilet Karakoç,Refika Ersu,Bülent Karadağ,Ela Erdem Eralp
DOI: https://doi.org/10.5152/ThoracResPract.2024.24018
2024-09-02
Abstract:Objective: Central sleep apnea (CSA) is a rare condition in children; however, it can cause significant morbidity if not diagnosed early. We aimed to increase the knowledge about CSA in children by describing the clinical characteristics of children diagnosed with CSA at our sleep center. Material and methods: We retrospectively reviewed 1263 polysomnographies (PSG) performed between 2012 and 2023 at our tertiary sleep center and evaluated the clinical characteristics of the patients with CSA. Underlying diseases, clinical symptoms, sleep parameters, and short-term management of the patients were recorded. Results: Of the 1263 patients aged between 1 month and 18 years, 122 (9.65%) had CSA, with 54.9 % (n = 67) of them being female. Only 56.6% (n = 69) of the patients' parents had reported a symptom indicating sleep-disordered breathing. The most common underlying disease was genetic, including Down and Prader-Willi syndromes, followed by neurological diseases . Obstructive sleep apnea was detected in addition to CSA in 103 of the patients (84.4%). Bi-level positive airway pressure with a backup rate was the most common treatment modality. Conclusion: While CSA is a rare clinical condition in children, it occurs more commonly in those with an underlying disease. Awareness of the disease and timely referral of the patients for sleep studies are critical to prevent long-term sequelae.
What problem does this paper attempt to address?